263 Results
Opposition to the Use of Cannabis for PTSD
The use of cannabis for medical indications has received considerable attention as several states have moved to legalize cannabis for various purposes. A growing number of patients cite post-traumatic stress disorder (PTSD) as the reason for seeking cannabis for medical purposes in states where it is legal.1 Furthermore, approximately 15% of Veterans who are treated in Department of Veterans Affairs (VA) outpatient PTSD clinics report recent (past 6 months) cannabis use.2 This position statement
Treatment of Opioid Use Disorder in the General Hospital
This Resource Document explores the pharmacology of opioid use disorder (OUD) treatment, education around OUD and its management, specialty-specific concerns, barriers to care, and an approach to reduction of stigma.
Peer review of expert testimony
The American legal system seeks justice through the adversarial process. The adversarial process, by its very nature, tends to highly polarize ideas. At times psychiatrists who testify as expert witnesses in court or similar settings have been perceived in the popular, legal and medical literature as either deficient in knowledge or to have knowingly behaved in an unethical manner to advance the cause of the party who hired them.(1-6) Sometimes these perceptions are not accurate. Other times the
Reclassification of ECT Devices
On December 26, 2018, the Food and Drug Administration (FDA) issued a final order regarding the reclassification of devices for administration of electroconvulsive therapy (ECT).i On the basis of device risk and the steps needed to give reasonable assurance of safety and effectiveness, the FDA categorizes medical devices into one of three classes (Class I, II, or III), with Class I devices generally posing the lowest risk to the patient.ii As part of a broader statutory requirement to re-categor
Telepsychiatry and Related Technologies in Clinical Psychiatry
The goal of this resource document is to address the major areas of the use of the internet in communication with patients and the public in the practice of psychiatry. The rate of change of technological capabilities and their implementation is so rapid that the workgroup believes that it would be inappropriate to promulgate fixed rules for constantly changing situations. Rather, we seek to provide some questions to be considered when implementing any new communication technology with patients
The Role of Psychiatrists in the Post-Roe Era
This resource document will outline clinical considerations for psychiatrists in a post-Dobbs world and provide guidance in navigating a new and complex landscape related to abortion.
Neuroimaging markers of psychiatric disorders, Consensus report of the APA Work Group on
In May 2009, an Action paper was passed by the APA Assembly calling for the development of an APA Position Paper on the Clinical Application of Brain Imaging in Psychiatry. This action paper was developed in response to questions raised by claims being made that brain imaging technology had already reached the point that it was useful for making a clinical diagnosis and for helping in treatment selection.
Position Statement on the Risk of Adolescents' Online Activity
Position Statement on the Risk of Adolescents' Online Activity
Position Statement on Issues Related to Sexual Orientation and Gender Minority Status
Position Statement on Issues Related to Sexual Orientation and Gender Minority Status
Position Statement on Religious Persecution and Genocide
Position Statement on Religious Persecution and Genocide
Position Statement on Diverse Representation in Medicine
Position Statement on Diverse Representation in Medicine
Position Statement on Concerns About Use of the Term Excited Delirium and Appropriate Medical
Position Statement on Concerns About Use of the Term Excited Delirium and Appropriate Medical